Home > Scientific Program > Program & Abstract Search
Chair : Taeyoung Yoon, PhD (Dong-A ST, SVP)
Induced pluripotent stem cell (iPSC) technology has provided unique opportunities for disease modeling, regenerative medicine and new drug discovery. In particular, the technology can shed new light on the cellular mechanism underlying brain disorders, for which human tissue samples are difficult to obtain. Here, we discuss how iPSC-based approaches can help expand our knowledge on brain disorders and enable targeted drug discovery.
1. Janghwan Kim, PhD (KRIBB, Reprogramming with pluripotency factors and disease modeling)
2. Jinju Han, PhD (KAIST, microRNAs regulating neurodevelopment and their associated diseases)
3. Jinsoo Seo, PhD (DGIST, The use of human iPSC in Alzheimer's disease research)
4. Ye Hwang Cheong, PhD (Dong-A ST, Drug discovery using iPSC platforms)
*Registration is not necessary, but we recommend it to reserve your lunch box!